SCHEMBL16092438

SCHEMBL16092438

CCS(=O)(=O)c1cccc(-c2[nH]c3c(C#N)cnn3c(=O)c2C(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 3/20 0.38
▸ KDM5A P29375 12/20 0.36
▸ KDM5B Q9UGL1 2/20 0.36
▸ KDM6B O15054 1/20 0.36
▸ KDM5C P41229 1/20 0.36
▸ KDM5D Q9BY66 1/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ PHF8 Q9UPP1 1/20 0.36
▸ KDM4D Q6B0I6 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ AOX1 Q06278 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ PLAT P00750 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17547835 0.90 FASN (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092320 0.88 KDM5A (0.36) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092340 0.88 TTK (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092493 0.84 KDM5B (0.48) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16092293 0.84 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092243 0.84 KDM5A (0.43) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092258 0.83 KDM5B (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17085740 0.83 KDM5A (0.39) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16050761 0.83 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092255 0.83 KDM5B (0.42) KDM5AKDM5BKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B BRD4 71/4885KDM5A 1/4885KDM5B 3/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B BRD4 71/4885KDM5A 1/4885KDM5B 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback